|
LOC729020 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.297780E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.725800E-02 |
| Normal-vs-Stage2 |
1.249800E-01 |
| Normal-vs-Stage3 |
4.817500E-03 |
| Normal-vs-Stage4 |
8.876300E-03 |
| Stage1-vs-Stage2 |
9.485200E-01 |
| Stage1-vs-Stage3 |
2.132000E-01 |
| Stage1-vs-Stage4 |
3.358800E-01 |
| Stage2-vs-Stage3 |
3.817800E-01 |
| Stage2-vs-Stage4 |
4.305000E-01 |
| Stage3-vs-Stage4 |
9.941600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.543580E-02 |
| Normal-vs-AfricanAmerican |
1.463390E-01 |
| Normal-vs-Asian |
1.126760E-01 |
| Caucasian-vs-AfricanAmerican |
8.075400E-01 |
| Caucasian-vs-Asian |
7.516000E-01 |
| AfricanAmerican-vs-Asian |
9.988800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.516300E-03 |
| Normal-vs-Female |
2.755900E-02 |
| Male-vs-Female |
1.942370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.056000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.822700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.607510E-02 |
| Normal-vs-Age(81-100Yrs) |
5.310300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.448600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.150600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.096400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.691400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.991000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.641400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.745800E-01 |
| Classical-VS-Follicular |
5.754400E-01 |
| Classical-VS-Other |
1.821820E-01 |
| Classical-VS-Normal |
2.436000E-02 |
| Tall-VS-Follicular |
2.349600E-01 |
| Tall-VS-Other |
7.488300E-02 |
| Tall-VS-Normal |
5.379400E-01 |
| Follicular-VS-Other |
3.544800E-01 |
| Follicular-VS-Normal |
2.303700E-02 |
| Other-VS-Normal |
2.155800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.060300E-02 |
| Normal-vs-N1 |
9.382700E-04 |
| N0-vs-N1 |
1.026430E-01 |
|
|
